NOCTURNAL MYOCLONUS IN PARKINSONIAN-PATIENTS UNDER LEVODOPA AND BROMOCRIPTINE

被引：0
|
作者：
VARDI, J [1 ]
GLOBMAN, H [1 ]
RABEY, JM [1 ]
STREIFLER, M [1 ]
机构：
[1] ICHILOV MUNICIPAL GOVT HOSP,TEL AVIV,ISRAEL
来源：
ISRAEL JOURNAL OF MEDICAL SCIENCES | 1979年 / 15卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [31] A GRAPHIC METHOD FOR EVALUATION OF PARKINSONIAN-PATIENTS UNDER TREATMENT
    FAIRMAN, D
    SCHWAB, RS
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1956, 4 (12) : 1240 - 1245
  • [32] INITIATION OF LEVODOPA THERAPY IN PARKINSONIAN-PATIENTS SHOULD BE DELAYED UNTIL THE ADVANCED STAGES OF THE DISEASE
    MELAMED, E
    ARCHIVES OF NEUROLOGY, 1986, 43 (04) : 402 - 405
  • [33] BIOAVAILABILITY AND ACCEPTABILITY OF A DISPERSIBLE FORMULATION OF LEVODOPA-BENSERAZIDE IN PARKINSONIAN-PATIENTS WITH AND WITHOUT DYSPHAGIA
    BAYER, AJ
    DAY, JJ
    FINUCANE, P
    PATHY, MSJ
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1988, 13 (03) : 191 - 194
  • [34] EVOLUTION OF SPEECH DISORDERS IN PARKINSONIAN-PATIENTS PRESENTING LONG-TERM LEVODOPA SYNDROMES
    BORROMEI, A
    PHARMACOLOGY, 1982, 24 (02) : 136 - 137
  • [35] Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients
    Agid, Y
    Destée, A
    Durif, F
    Montastruc, JL
    Pédarriosse, AM
    Deptula, D
    Hoffman-La Roche, F
    Pollak, P
    Bonnet, AM
    Allain, H
    le Cavorzin, P
    Barroche, G
    Blin, O
    Césaro, P
    Chazot, G
    Broussolle, E
    Leduc, V
    Debilly, B
    Fève, JR
    Géraud, G
    Fabre, N
    Gu, C
    Gil, R
    Henry, P
    Tison, F
    Ansquer, O
    Brefel, C
    Payen, I
    Saïd, G
    Planté, V
    Touchon, J
    Césari, JB
    Camu, W
    Bennys, K
    Viallet, F
    Warter, JM
    Tranchant, C
    Ziegler, M
    MOVEMENT DISORDERS, 1999, 14 (01) : 38 - 44
  • [36] DECREASED EFFICACY OF LEVODOPA WITH CARBIDOPA IN PARKINSONIAN-PATIENTS AFTER ADRENAL-TO-CAUDATE IMPLANTS
    TSUI, JKC
    PEPPARD, RF
    PETRUK, KC
    ALLEN, G
    BURNS, RS
    CALNE, DB
    NEUROLOGY, 1990, 40 (05) : 845 - 846
  • [37] COMBINATION OF SELEGILINE AND CONTROLLED RELEASE LEVODOPA IN THE TREATMENT OF FLUCTUATIONS OF CLINICAL DISABILITY IN PARKINSONIAN-PATIENTS
    CHOUZA, C
    ALJANATI, R
    SCARAMELLI, A
    DEMEDINA, O
    CAAMANO, JL
    BUZO, R
    FERNANDEZ, A
    ROMERO, S
    ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 : 127 - 137
  • [38] DIGITAL ANALYSIS OF THE EFFECTS OF LEVODOPA TREATMENT ON THE VISUAL EVOKED-RESPONSE IN PARKINSONIAN-PATIENTS
    YAAR, I
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1979, 15 (03): : 296 - 296
  • [39] INFLUENCE OF MEAL INGESTION TIME ON PHARMACOKINETICS OF ORALLY-ADMINISTERED LEVODOPA IN PARKINSONIAN-PATIENTS
    BARUZZI, A
    CONTIN, M
    RIVA, R
    PROCACCIANTI, G
    ALBANI, F
    TONELLO, C
    ZONI, E
    MARTINELLI, P
    CLINICAL NEUROPHARMACOLOGY, 1987, 10 (06) : 527 - 537
  • [40] A WALKING AID FOR PARKINSONIAN-PATIENTS
    PEARCE, JMS
    LANCET, 1993, 342 (8862): : 62 - 62
12345